Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription 14.09.2026 2 Biochem Biophys Res Commun 1 BMC Cancer 2 BMC Gastroenterol 7 Dig Dis Sci 1 Endoscopy 1 Eur Radiol 1 Gastrointest Endosc 7 Gut 2 Int J Cancer 2 J Hepatol 1 N Engl J Med 2 PLoS One 1 Radiol Imaging Cancer 1 Radiology 1 Semin Liver Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biochem Biophys Res Commun

1. XIAO Z, Bian H, Huang Y
   Integrative multi-omics and machine learning identify the SPI1-METTL16-PLIN4 axis as a candidate driver of steatosis in HepG2 cells.
   Biochem Biophys Res Commun. 2026;834:154435.
   PubMed         Abstract available
   
   
2. SHIMODE T, Kawaguchi K, Honda M, Li YY, et al
   Hepatocyte growth factor in liver sinusoidal endothelial cells regulates hepatitis B virus replication in hepatocytes.
   Biochem Biophys Res Commun. 2026;836:154565.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. WANG J, Li Z, Cheng Y, You L, et al
   Reduction of cancer cell quantity and viability in autologous blood salvaged from patients with liver cancer: efficacy of intraoperative cell salvage coupled with leukocyte depletion filtration.
   BMC Cancer. 2026;26:1070.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

4. ZHENG M, Lei H, He H, Huang Y, et al
   Prognostic nutritional index as a predictor of ursodeoxycholic acid response in primary biliary cholangitis: a retrospective study.
   BMC Gastroenterol. 2026 Jun 24. doi: 10.1186/s12876-026-05040.
   PubMed         Abstract available
   
   
5. HE H, Yan Y, Zhang Y
   Comparison of proton vs. photon radiotherapy for liver cancer: a meta-analysis.
   BMC Gastroenterol. 2026;26:544.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

6. PAN JJ, Horwich BH, Chahine M, Gutierrez JA, et al
   Selecting Pharmacologic Interventions for MASH.
   Dig Dis Sci. 2026;71:5219-5227.
   PubMed         Abstract available
   
   
7. HASHIMOTO R, Tanaka T, Chang KJ
   Endoscopic Ultrasound-Guided Versus Transjugular Portal Pressure Measurements: Systematic Review and Meta-Analysis.
   Dig Dis Sci. 2026;71:4873-4882.
   PubMed         Abstract available
   
   
8. PEKARSKA K, Rowe I, Parker R
   Incidence of Cardiovascular Events and Extrahepatic Malignancies in Steatotic Liver Disease Subgroups.
   Dig Dis Sci. 2026;71:4794-4803.
   PubMed         Abstract available
   
   
9. LESLIE ZD, Ahmed K, Ali Y, Wise ES, et al
   High-Risk Comorbidities Drive Adverse Inpatient Outcomes After ERCP: A National Analysis and Predictive Model.
   Dig Dis Sci. 2026;71:4756-4763.
   PubMed         Abstract available
   
   
10. DENG LX, Catalli L, Miller S, Sherman C, et al
    Palliative Care Co-management at a Liver Transplant Center: A Mixed Methods Study.
    Dig Dis Sci. 2026 May 28. doi: 10.1007/s10620-026-10034.
    PubMed         Abstract available
    
    
11. ELKIN B, Alabbas M, Yang Q, Brandon B, et al
    Psoas Muscle Trajectory and Survival After Liver Transplantation for Steatotic Liver Disease in Severe Obesity.
    Dig Dis Sci. 2026 May 22. doi: 10.1007/s10620-026-10004.
    PubMed         Abstract available
    
    
12. ALABBAS M, Alnounou A, Ibrahim EA, Karam AM, et al
    Statin Continuation After an Index Hospitalization for Hepatic Decompensation in MASLD Cirrhosis.
    Dig Dis Sci. 2026 Sep 8. doi: 10.1007/s10620-026-10236.
    PubMed         Abstract available
    
    

    
    Endoscopy

13. CHEN T, Zhang J, Chen R, Zhang J, et al
    Percutaneous transhepatic cholangioscopy- guided recanalization and reconstruction of Iatrogenic right hepatic duct occlusion with endoscopic assistance.
    Endoscopy. 2026 Sep 8. doi: 10.1055/a-2946-2091.
    PubMed        
    
    

    
    Eur Radiol

14. VOLLBRECHT TM, Mesropyan N, Chang J, Kravchenko D, et al
    Long-term cardiac remodeling after transjugular intrahepatic portosystemic shunt placement: a cardiac MRI study.
    Eur Radiol. 2026 Sep 9. doi: 10.1007/s00330-026-12861.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

15. KOHLI DR, Smith P, Simanonok MP, Phelps KC, et al
    A PROSPECTIVE CLINICAL TRIAL OF EUS-SHEAR WAVE MEASUREMENT OF LIVER AND SPLEEN FOR HEPATIC FIBROSIS.
    Gastrointest Endosc. 2026 Sep 9:S0016-5107(26)07040.
    PubMed         Abstract available
    
    

    
    Gut

16. MA J, Wu T, Chen D, Zhu C, et al
    S1P-TREM2 axis protects immunosuppressive neutrophils from ferroptosis to promote tumour progression in hepatocellular carcinoma.
    Gut. 2026 Sep 7:gutjnl-2025-337414. doi: 10.1136/gutjnl-2025-337414.
    PubMed         Abstract available
    
    
17. PATEL VC, Shawcross DL, Leeds JS, Corless L, et al
    From ambition to delivery: why realistic research matters in UK gastroenterology and hepatology.
    Gut. 2026 Sep 11:gutjnl-2026-339954. doi: 10.1136/gutjnl-2026-339954.
    PubMed        
    
    
18. COLWILL M, Bhakta A, Patel N, Sadler G, et al
    Unusual mass at the hepatic flexure.
    Gut. 2026 Sep 7:gutjnl-2026-340480. doi: 10.1136/gutjnl-2026-340480.
    PubMed        
    
    
19. RANA VS, Nain J, Bhagat N, De A, et al
    Rapid muscle loss in cirrhosis: competing risks, scan timing and regression to the mean.
    Gut. 2026 Sep 7:gutjnl-2026-340341. doi: 10.1136/gutjnl-2026-340341.
    PubMed        
    
    
20. CHEN L, Li P, Park MJ, Chen Z, et al
    CPS1: a multipurpose mitochondrial enzyme, bile protein, acute liver injury biomarker, and cytokine.
    Gut. 2026 Feb 2:gutjnl-2024-333082. doi: 10.1136/gutjnl-2024-333082.
    PubMed         Abstract available
    
    
21. TICA S, Luo C, Ren D, Zong X, et al
    Parental obesity and risk of metabolic dysfunction associated steatotic liver disease in adult offspring: UK birth cohort study.
    Gut. 2026;75:2019-2027.
    PubMed         Abstract available
    
    
22. WU CT, Targher G, Byrne CD, Younossi ZM, et al
    Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement.
    Gut. 2026 Jan 21:gutjnl-2025-337374. doi: 10.1136/gutjnl-2025-337374.
    PubMed         Abstract available
    
    

    
    Int J Cancer

23. ZHAO J, Li K, Zhang Y, Chen Y, et al
    Liver Cancer Risk and Incidence Attributable to Human Immunodeficiency Virus: A Meta-Analysis and Population-Attributable Modeling Study of Over 1.2 Million Individuals.
    Int J Cancer. 2026 Jun 11. doi: 10.1002/ijc.70587.
    PubMed         Abstract available
    
    
24. LI D, Zhou Z, Liang G, Zeng D, et al
    Association Between Allostatic Load, Genetic Susceptibility, and Liver Cancer Incidence: A Large-Scale Prospective Cohort Study.
    Int J Cancer. 2026;159:2158-2169.
    PubMed         Abstract available
    
    

    
    J Hepatol

25. WANG X, He Q, Shen H, Xia A, et al
    Corrigendum to 'TOX promotes the exhaustion of antitumor CD8(+) T cells by preventing PD1 degradation in hepatocellular carcinoma' [J hepatol (2019) 71(4):731-741; doi: 10.1016/j.jhep.2019.05.015].
    J Hepatol. 2026 Sep 8:S0168-8278(26)02874-6. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
26. XIE M, Lin Z, Ji X, Luo X, et al
    Corrigendum to: "FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2" [J Hepatol (2023) 79(1):109-125; DOI: 10.1016/j.jhep.2023.02.036].
    J Hepatol. 2026 Sep 10:S0168-8278(26)02886-2. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    

    
    N Engl J Med

27. STEFFIN D, Courtney AN, Choe M, Ghatwai N, et al
    Complete Regression of Hepatoblastoma after Interleukin-15- and Interleukin-21-Coexpressing CAR T-Cell Therapy.
    N Engl J Med. 2026;395:1029-1032.
    PubMed        
    
    

    
    PLoS One

28. LIU D, Ji H, Chen Y, Zhou T, et al
    Body mass index modifies the association between occupational noise exposure duration and ultrasound?detected hepatic steatosis: A cross-sectional study among male factory workers.
    PLoS One. 2026;21:e0358275.
    PubMed         Abstract available
    
    
29. ZHANG T, Yuan Y, Lin C, Song C, et al
    Environmental PFOA exposure and the risk of metabolic dysfunction-associated steatotic liver disease: An integrated computational toxicology and multi-omics study.
    PLoS One. 2026;21:e0357970.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

30. CHLOROGIANNIS DD, Bhagavatula SK, Silverman SG, Dabiri BE, et al
    Percutaneous Cryoablation Versus Microwave Ablation for Hepatocellular Carcinoma: Comparative Study of Safety and Oncologic Outcomes.
    Radiol Imaging Cancer. 2026;8:e250442.
    PubMed         Abstract available
    
    

    
    Radiology

31. LUO S, Wei X, Lu X, Wang Z, et al
    Histotripsy for Hepatocellular Carcinoma: From Bench to Bedside.
    Radiology. 2026;320:e254050.
    PubMed         Abstract available
    
    

    
    Semin Liver Dis

32. SEGNA D, Ojeda A, Torres S, Garcia-Pagan JC, et al
    Expert Practical Recommendations for Portal Hypertension in Cirrhosis.
    Semin Liver Dis. 2026 Sep 10. doi: 10.1055/a-2956-4625.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum